Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-02-28
1998-05-05
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 530324, 530326, 530327, A61K 3816, A61K 3810, C07K 1400, C07K 700
Patent
active
057474516
ABSTRACT:
Peptide derivatives represented by the formula (I): ##STR1## which can specifically bind to modified LDL in competition with scavenger receptors on macrophages and are useful in diagnosing, preventing and treating circulatory diseases caused by accumulation of modified LDL in macrophages.
REFERENCES:
Fields, "Mini-Collagens" (1993) Caplus # 1995:69258.
Fields, "Synthesis Collagen Sequences" (1993) Biosis # 94:12188.
C. Fields et al., "Solid-Phase Synthesis and Stability of Triple-Helical Peptides Incorporating Native Collagen Sequences", Biopolymers, vol. 33, Issue 10, pp. 1695-1707, Oct. 1993.
T. Tanaka et al., "A Synthetic Model of Collagen Structure taken from Bovine Macrophage Scavenger Receptor", FEBS 13257, vol. 334, No. 3, pp. 272-276, Nov. 1993.
Doi Takefumi
Imanishi Takeshi
Kodama Tatsuhiko
Nakamura Haruki
Tanaka Toshiki
Delaney Patrick R.
Protein Engineering Research Institute
Tsang Cecilia J.
LandOfFree
Peptide derivatives having binding activity to modified low dens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide derivatives having binding activity to modified low dens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide derivatives having binding activity to modified low dens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54522